Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Polyclonal ERCC3 Primary Antibody for ChIP, IP - ABIN253199
Gray, Vallur, Eddy, Maizels: G quadruplexes are genomewide targets of transcriptional helicases XPB and XPD. in Nature chemical biology 2014
Cow (Bovine) Polyclonal ERCC3 Primary Antibody for WB - ABIN2780326
Vijai, Topka, Villano, Ravichandran, Maxwell, Maria, Thomas, Gaddam, Lincoln, Kazzaz, Wenz, Carmi, Schrader, Hart, Lipkin, Neuhausen, Walsh, Zhang, Lejbkowicz, Rennert, Stadler, Robson, Weitzel et al.: A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer. ... in Cancer discovery 2016
An essential role of MYC (show MYC Antibodies)-ERCC3 interactions in PDAC.
similar to tumors arising in the background of homologous repair defects, mutations in nucleotide excision repair genes such as ERCC3 could constitute potential therapeutic targets in a subset of hereditary breast cancers.
results reveal a previously unknown role for transcription factor IIH in ATR kinase activation in non-replicating, non-cycling cells
Study shows that: mRNA synthesis is sensitive to the inhibition of the ATPase (show DNAH8 Antibodies) activity of XPB (show GTF2H5 Antibodies); mRNA synthesis accommodates the depletion of XPB (show GTF2H5 Antibodies); XPB (show GTF2H5 Antibodies)-depleted TFIIH (show GTF2H1 Antibodies) participates in mRNA synthesis, and finally, XPB (show GTF2H5 Antibodies) ATPase (show DNAH8 Antibodies) overcomes transcription initiation block imposed by its helicase motifs.
significant interactions between ERCC2 (show ERCC2 Antibodies) (Lys751Gln) and ERCC3 (7122 A>G) genotypes polymorphism and cadmium exposure in association with nasal polyposis disease
Data did not find any association between ERCC2 (show ERCC2 Antibodies) or ERCC3 gene polymorphisms and the development of osteosarcoma.
Transcriptional differences found between various TFIIH subunit (show GTF2H4 Antibodies) variants participate in the phenotypic variability observed among xeroderma pigmentosum, XP associated with Cockayne syndrome, and trichothiodystrophy individuals.
XPB (show GTF2H5 Antibodies) and XPD (show ERCC2 Antibodies) enrichment at G4 motifs characterizes specific signaling pathways and regulatory pathways associated with specific cancers
findings suggest that benzene exposure may be associated with hypermethylation in ERCC3, and that genetic variants in EPHX1 (show EPHX1 Antibodies) may play an important role in epigenetic changes and hematotoxicity among benzene-exposed workers
The crystal structure of the C-terminal half of the XPB (show GTF2H5 Antibodies) subunit of TFIIH (show GTF2H1 Antibodies) (residues 494-782) is reported, containing XPB (show GTF2H5 Antibodies) helicase domain (HD)2 (show HDAC2 Antibodies) and a C-terminal extension which shares structural similarity with RIG-I (show DDX58 Antibodies).
ERCC3 is an ATP-dependent DNA helicase that functions in nucleotide excision repair and complements xeroderma pigmentosum group B mutations. It also is the 89 kDa subunit of basal transcription factor 2 (TFIIH) and thus functions in class II transcription.
excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing)
, BTF2 p89
, DNA excision repair protein ERCC-3
, DNA repair protein complementing XP-B cells
, TFIIH 89 kDa subunit
, TFIIH basal transcription factor complex 89 kDa subunit
, TFIIH basal transcription factor complex helicase XPB subunit
, TFIIH p89
, basic transcription factor 2 89 kDa subunit
, xeroderma pigmentosum group B-complementing protein
, xeroderma pigmentosum, complementation group B
, excision repair 3